Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Armata Pharmaceuticals, Inc.

5.31
-1.4600-21.57%
Post-market: 5.26-0.0454-0.85%17:12 EST
Volume:184.75K
Turnover:1.06M
Market Cap:192.91M
PE:-2.39
High:6.72
Open:6.57
Low:5.21
Close:6.77
52wk High:16.34
52wk Low:0.8981
Shares:36.33M
Float Shares:10.87M
Volume Ratio:4.27
T/O Rate:1.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2230
EPS(LYR):-0.5231
ROE:-3439.35%
ROA:-22.20%
PB:-2.02
PE(LYR):-10.15

Loading ...

OverviewCompanyNewsFilings

Armata says diSArm study confirms efficacy of intravenous phage therapy for SAB

TIPRANKS
·
Oct 22

Armata Pharmaceuticals Reports Positive Phase 2a Results for AP-SA02 in Staphylococcus aureus Bacteremia

Reuters
·
Oct 22

Armata Pharmaceuticals trading halted, news pending

TIPRANKS
·
Oct 22

Amex Halt News Pending Lst 3.491300

THOMSON REUTERS
·
Oct 22

Armata Pharmaceuticals to Present Phase 2a Clinical Data on AP-SA02 Bacteriophage Therapy for Staphylococcus aureus Bacteremia at IDWeek 2025

Reuters
·
Oct 14

Armata Pharmaceuticals Inc: Files for Mixed Shelf of up to $100 Mln - Filing

THOMSON REUTERS
·
Aug 14

Armata Pharmaceuticals Reports Q2 2025 Results: $6.8M Loss from Operations, $2.2M Grant Revenue Recognized

Reuters
·
Aug 13

Armata Pharmaceuticals Inc. Conducted Annual Shareholders Meeting

Reuters
·
Jun 14

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Nov 12, 2025 Post Market
Financial Report Announcement
Aug 22, 2025 Pre-Market
Financial Report Announcement
May 14, 2025 Post Market
Financial Report Announcement
Mar 20, 2025 Post Market
Financial Report Announcement
Nov 13, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-2.39
Current
-12.19
Sector Average
18.43%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-2.39
Maximum
-0.97
+1 STD
26.67
Minimum
-211.13
-1 STD
-51.05
Average
-12.19

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.